Nicolò Pecorelli1,2, Giovanni Guarneri1,2, Marco Palucci2, Lorenzo Gozzini2, Alessia Vallorani2, Stefano Crippa1,2, Stefano Partelli1,2, Massimo Falconi3,4. 1. Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milano, Italy. 2. Vita-Salute San Raffaele University, Milan, Italy. 3. Division of Pancreatic Surgery, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute, Via Olgettina 60, 20132, Milano, Italy. falconi.massimo@hsr.it. 4. Vita-Salute San Raffaele University, Milan, Italy. falconi.massimo@hsr.it.
Abstract
BACKGROUND: Recent evidence suggests that pancreatic inflammation plays a pivotal role in the occurrence of clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy but few data are available for distal pancreatectomy (DP). The aim of this study was to evaluate the impact of early biochemical markers on the occurrence of CR-POPF after DP. METHODS: Clinical and laboratory data for 432 consecutive DP patients were reviewed. Serum amylase was evaluated on postoperative day (POD) 1, and drain fluid amylase (DFA) and C-reactive protein (CRP) were evaluated on POD 2 and 3. Receiver operator characteristic (ROC) curves were performed for all biochemical markers and an area under the curve (AUC) was computed. Multivariable regression analyses to identify the factors associated with CR-POPF and severe postoperative morbidity (Clavien-Dindo grade ≥ 3) were performed. RESULTS: At 90 days after surgery, CR-POPF occurred in 155 (36%) patients, severe complications in 66 (15%) patients. ROC curve analyses showed that DFA on POD2 had the largest AUC (0.753, p < 0.001), followed by serum amylase on POD 1 (0.651, p < 0.001), serum CRP on POD3 (0.644, p < 0.001), and CRP change between POD 2 and POD 3 (0.644, p < 0.001). Multivariable analysis identified male gender (OR 2.29, 95% CI 1.36-3.86; p = 0.002), DFA ≥ 1500 U/L on POD2 (OR 4.63, 95% CI 2.72-7.89; p < 0.001), serum amylase ≥ 100 U/L on POD 1 (OR 1.72, 95% CI 1.01-2.93; p = 0.046), and CRP increase by at least 25 mg/L on POD 3 compared to the previous day (OR 1.89, 95% CI 1.11-3.21; p = 0.019) as independent predictors of CR-POPF, yielding a valid regression model (AUC 0.765, 95% CI 0.714-0.816, p < 0.001). CONCLUSIONS: Postoperative serum amylase and CRP trajectory represent useful early biochemical markers for CR-POPF in addition to DFA. Our findings suggest that these laboratory tests should be incorporated into clinical practice to aid postoperative patient and drain management.
BACKGROUND: Recent evidence suggests that pancreatic inflammation plays a pivotal role in the occurrence of clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy but few data are available for distal pancreatectomy (DP). The aim of this study was to evaluate the impact of early biochemical markers on the occurrence of CR-POPF after DP. METHODS: Clinical and laboratory data for 432 consecutive DP patients were reviewed. Serum amylase was evaluated on postoperative day (POD) 1, and drain fluid amylase (DFA) and C-reactive protein (CRP) were evaluated on POD 2 and 3. Receiver operator characteristic (ROC) curves were performed for all biochemical markers and an area under the curve (AUC) was computed. Multivariable regression analyses to identify the factors associated with CR-POPF and severe postoperative morbidity (Clavien-Dindo grade ≥ 3) were performed. RESULTS: At 90 days after surgery, CR-POPF occurred in 155 (36%) patients, severe complications in 66 (15%) patients. ROC curve analyses showed that DFA on POD2 had the largest AUC (0.753, p < 0.001), followed by serum amylase on POD 1 (0.651, p < 0.001), serum CRP on POD3 (0.644, p < 0.001), and CRP change between POD 2 and POD 3 (0.644, p < 0.001). Multivariable analysis identified male gender (OR 2.29, 95% CI 1.36-3.86; p = 0.002), DFA ≥ 1500 U/L on POD2 (OR 4.63, 95% CI 2.72-7.89; p < 0.001), serum amylase ≥ 100 U/L on POD 1 (OR 1.72, 95% CI 1.01-2.93; p = 0.046), and CRP increase by at least 25 mg/L on POD 3 compared to the previous day (OR 1.89, 95% CI 1.11-3.21; p = 0.019) as independent predictors of CR-POPF, yielding a valid regression model (AUC 0.765, 95% CI 0.714-0.816, p < 0.001). CONCLUSIONS: Postoperative serum amylase and CRP trajectory represent useful early biochemical markers for CR-POPF in addition to DFA. Our findings suggest that these laboratory tests should be incorporated into clinical practice to aid postoperative patient and drain management.
Authors: Yi Miao; Zipeng Lu; Charles J Yeo; Charles M Vollmer; Carlos Fernandez-Del Castillo; Paula Ghaneh; Christopher M Halloran; Jörg Kleeff; Thijs de Rooij; Jens Werner; Massimo Falconi; Helmut Friess; Herbert J Zeh; Jakob R Izbicki; Jin He; Johanna Laukkarinen; Cees H Dejong; Keith D Lillemoe; Kevin Conlon; Kyoichi Takaori; Luca Gianotti; Marc G Besselink; Marco Del Chiaro; Marco Montorsi; Masao Tanaka; Maximilian Bockhorn; Mustapha Adham; Attila Oláh; Roberto Salvia; Shailesh V Shrikhande; Thilo Hackert; Tooru Shimosegawa; Amer H Zureikat; Güralp O Ceyhan; Yunpeng Peng; Guangfu Wang; Xumin Huang; Christos Dervenis; Claudio Bassi; John P Neoptolemos; Markus W Büchler Journal: Surgery Date: 2020-04-02 Impact factor: 3.982
Authors: George Van Buren; Mark Bloomston; Carl R Schmidt; Stephen W Behrman; Nicholas J Zyromski; Chad G Ball; Katherine A Morgan; Steven J Hughes; Paul J Karanicolas; John D Allendorf; Charles M Vollmer; Quan Ly; Kimberly M Brown; Vic Velanovich; Jordan M Winter; Amy L McElhany; Peter Muscarella; Christian Max Schmidt; Michael G House; Elijah Dixon; Mary E Dillhoff; Jose G Trevino; Julie Hallet; Natalie S G Coburn; Attila Nakeeb; Kevin E Behrns; Aaron R Sasson; Eugene P Ceppa; Sherif R Z Abdel-Misih; Taylor S Riall; Eric J Silberfein; Edwin C Ellison; David B Adams; Cary Hsu; Hop S Tran Cao; Somala Mohammed; Nicole Villafañe-Ferriol; Omar Barakat; Nader N Massarweh; Christy Chai; Jose E Mendez-Reyes; Andrew Fang; Eunji Jo; Qianxing Mo; William E Fisher Journal: Ann Surg Date: 2017-09 Impact factor: 12.969
Authors: Brett L Ecker; Matthew T McMillan; Valentina Allegrini; Claudio Bassi; Joal D Beane; Ross M Beckman; Stephen W Behrman; Euan J Dickson; Mark P Callery; John D Christein; Jeffrey A Drebin; Robert H Hollis; Michael G House; Nigel B Jamieson; Ammar A Javed; Tara S Kent; Michael D Kluger; Stacy J Kowalsky; Laura Maggino; Giuseppe Malleo; Vicente Valero; Lavanniya K P Velu; Amarra A Watkins; Christopher L Wolfgang; Amer H Zureikat; Charles M Vollmer Journal: Ann Surg Date: 2019-01 Impact factor: 12.969
Authors: Thijs de Rooij; Jony van Hilst; Hjalmar van Santvoort; Djamila Boerma; Peter van den Boezem; Freek Daams; Ronald van Dam; Cees Dejong; Eino van Duyn; Marcel Dijkgraaf; Casper van Eijck; Sebastiaan Festen; Michael Gerhards; Bas Groot Koerkamp; Ignace de Hingh; Geert Kazemier; Joost Klaase; Ruben de Kleine; Cornelis van Laarhoven; Misha Luyer; Gijs Patijn; Pascal Steenvoorde; Mustafa Suker; Moh'd Abu Hilal; Olivier Busch; Marc Besselink Journal: Ann Surg Date: 2019-01 Impact factor: 12.969
Authors: Eric Chong; Bathiya Ratnayake; Shiela Lee; Jeremy J French; Colin Wilson; Keith J Roberts; Benjamin P T Loveday; Derek Manas; John Windsor; Steve White; Sanjay Pandanaboyana Journal: HPB (Oxford) Date: 2021-03-18 Impact factor: 3.647
Authors: Nora Jahn; Maria Theresa Voelker; Sven Laudi; Sebastian Stehr; Stefan Schneeberger; Gerald Brandacher; Elisabeth Sucher; Sebastian Rademacher; Daniel Seehofer; Robert Sucher; Hans Michael Hau Journal: J Clin Med Date: 2022-05-03 Impact factor: 4.964